Bunazosin Hydrochloride

CAS No:
52712-76-2 Category:
  • #LGM Pharma is a Bunazosin Hydrochloride CAS# 52712-76-2 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, delivery, purity, and more.
  • #Questions? Call our customer API support number 1-(800)-881-8210.
  • #LGM Pharma offers this active ingredient but not the finished dosage forms.

Product Details:

  • CAS No: 52712-76-2
  • AHFC code:
  • Synonyms: 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1-oxobutyl)hexahydro-1H-1,4-diazepine monohydrochloride, 4-Amino-2-(4-butanoylhexahydro-1H-1,4-diazepin-1-yl)-6,7-dimethoxyquinazoline hydrochloride, Bunazocine hydrochloride, Bunazosin HCl, Bunazosin hydrochloride, DDQ, DDQ (pharmaceutical), Detantol, E-643, E643, UNII-18V54TZ7U6
  • ATC Code:
  • Chemical Formula: C19-H27-N5-O3.Cl-H
  • Molecular Weight: 409.9152
  • Assay/Purity: Typically NLT 98%
  • DrugBank:
  • SMILES: CCCC(=O)N1CCCN(CC1)c2nc3cc(c(cc3c(n2)N)OC)OC.Cl
  • InChl: 1S/C19H27N5O3.ClH/c1-4-6-17(25)23-7-5-8-24(10-9-23)19-21-14-12-16(27-3)15(26-2)11-13(14)18(20)22-19;/h11-12H,4-10H2,1-3H3,(H2,20,21,22);1H
  • PubChem:
  • IUPAC: 1H-1,4-Diazepine, hexahydro-1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(1-oxobutyl)-, monohydrochloride

Additional Details

Indication:
Pharmacodynamics:
Mode of Action:
Metabolism:
Toxicity:
General Reference:
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Cost effective materials based on specific requirements
  • Small quantities for initial research and larger development quantities towards product commercialization

 

  • Technical packages, letters of access to filed DMFs
  • Complete assistance in any regulatory filings
  • Top quality GMP certified manufacturers
  • Have necessary regulatory credentials